TipRanks
Go Ultimate55% OFF

SCOR SE (SCRYY) AI Stock Analysis

SCRYY

SCOR SE

(Other OTC:SCRYY)

Select Model
Rating:78Outperform
Price Target:$4.50â–²(13.92% Upside)
Action:reiterated
Date:11/01/26

The score is supported primarily by solid financial recovery and a very strong earnings update, with additional support from favorable technical momentum and attractive valuation. Margin pressure, moderate leverage, and a softening reinsurance market prevent a higher score.

Positive Factors
P&C Underwriting QualityA low combined ratio indicates that SCOR is currently converting premiums into underwriting profit with meaningful efficiency. Continued reserve strengthening and disciplined risk selection can improve resilience, support capital generation, and help preserve profitability through changing reinsurance conditions.
Negative Factors
P&C Pricing PressurePersistent competition and falling catastrophe prices can compress future underwriting margins even when loss experience remains favorable. SCOR’s emphasis on margin over volume helps mitigate the risk, but renewal pressure could still reduce the profitability of newly written business.

SCOR SE (SCRYY) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%50%SCRYY+36.57%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$70.57B
Dividend Yield
5.80%
Average Volume (3M)
2,973
Price to Earnings (P/E)
7.6
Beta (1Y)
0.48
Revenue Growth
1.03%
EPS Growth
-2.51%
Country
US
Employees
3,610
Sector
Financial
Sector Strength
68
Industry
Insurance - Reinsurance

SCOR SE Business Overview & Revenue Model

Company Description

SCOR SE functions as a prominent global reinsurance provider, offering a comprehensive suite of life and non-life protection solutions. The company boasts a broad international footprint, serving clients across Europe, the Middle East, Africa, the Am...

How the Company Makes Money

SCOR makes money mainly through (1) underwriting reinsurance and (2) investment income on the assets it holds to pay future claims. 1) Underwriting reinsurance premiums (core revenue) - P&C reinsurance: SCOR enters reinsurance contracts with primary...

SCOR SE Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q3-2026)|% Change Since:7.16%|Next Earnings Date:Mar 09, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. SCOR reported robust profitability, capital strength, economic value growth above target, strong P&C underwriting performance, consistent Life & Health results, and positive investment income. Management acknowledged meaningful challenges from P&C market softening, pricing pressure, catastrophe and other losses, EGPI revisions, and selected business exits, but described these risks as understood and incorporated into its plans. The highlights significantly outweighed the lowlights.

Positive Updates

Strong Nine-Month Net Income and Return on Equity
Group net income reached EUR 615 million in the first 9 months, corresponding to an annualized return on equity of 19.3%, despite increased competition in P&C, a negative one-off arbitration impact in Life & Health in the second quarter, and continued buffer building in P&C.

Negative Updates

Continued P&C Market Softening and Competition
Management said competition remains high and the P&C market is softening. The company expects further softening to be reflected in its new strategic plan and does not assume a blue-sky scenario.

Company Guidance

SCOR expects competition to remain high at the 1st of January 2027 renewals, with margin and quality over volume, and expects price decreases in cat of high single digit, low double digit; the outlook for '27 is something in line with what we saw in '26 so far. Management estimates the deterioration between '25 and '26 to be limited to approximately 2 points of combined ratio, expects to continue to build buffers, and said the cat exposure does not change the 10% guidance. SBS is expected to show some growth and continue to be a good driver of revenue growth, while SCOR expects to reach its objective of neutral or positive cash flow on the Life & Health side in 2026; the Solvency II review guidance remains 10% to 15%, and the Forward 2026 targets include 12% ROE and 9% annual growth.

SCOR SE Financial Statement Overview

Summary

Strong revenue recovery, positive earnings, 18.4% ROE, and substantial free cash flow support the score. Softer margins, modestly lower net income and equity, and moderate leverage limit it.

Income Statement

75Positive

Balance Sheet

70Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.57B14.80B15.65B15.84B16.44B15.99B
Gross Profit9.69B13.96B14.83B15.16B12.61B12.11B
EBITDA943.10M1.56B520.00M1.58B-1.32B1.23B
Net Income807.83M851.00M4.00M812.00M-1.38B456.00M
Balance Sheet
Total Assets37.32B36.08B37.35B35.61B34.70B47.52B
Cash, Cash Equivalents and Short-Term Investments2.10B2.08B2.39B1.86B1.81B2.09B
Total Debt3.29B3.43B3.45B3.23B3.24B3.17B
Total Liabilities32.94B31.66B32.82B30.87B30.38B41.10B
Stockholders Equity4.38B4.43B4.52B4.71B4.28B6.40B
Cash Flow
Free Cash Flow952.36M973.02M875.00M1.45B430.00M2.32B
Operating Cash Flow1.00B1.01B903.00M1.48B500.00M2.41B
Investing Cash Flow-153.45M-848.15M-181.00M-954.00M-269.00M-1.54B
Financing Cash Flow-853.47M-347.71M-213.00M-428.00M-567.00M-674.00M

SCOR SE Technical Analysis

Technical Analysis SentimentPositive
Last Price3.95

Price Trends

50DMA3.76Positive
100DMA3.76Positive
200DMA3.60Positive

Market Momentum

MACD0.00Negative
RSI61.94Neutral
STOCH45.08Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCRYY, the sentiment is Positive. The current price of 3.95 is above the 20-day moving average (MA) of 3.69, above the 50-day MA of 3.76, and above the 200-day MA of 3.60, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 61.94 is Neutral, neither overbought nor oversold. The STOCH value of 45.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCRYY.

SCOR SE Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

SCRYY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AXSAXS78Outperform$7.52B7.0117.80%1.68%10.16%7.89%
RGARGA78Outperform$17.29B11.5011.29%1.42%19.54%97.85%
SCRYYSCRYY78Outperform$6.91B7.5918.37%5.80%1.03%-2.51%
RNRRNR76Outperform$13.71B9.6614.82%0.48%-21.18%-3.27%
SPNTSPNT76Outperform$3.01B6.2421.84%―22.55%371.77%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
EGEG65Neutral$15.76B8.7512.52%1.95%-8.72%250.85%

* Financial Sector Average

Performance Comparison

0%20%40%SCRYYAXSEGRGARNRSPNTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
SCRYY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SCRYYSCOR SE (ADR)3.860.9834.28%
AXSAxis Capital Holdings104.8712.1313.08%
EGEverest Group, Ltd.410.97104.9534.30%
RGAReinsurance Group Of America264.7386.3348.39%
RNRRenaissancere339.3284.7333.28%
SPNTSiriuspoint Ltd25.887.0037.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 01, 2026